Due to an emerging gap between small research firms and large pharmaceutical companies, research ideas with great potential have limited opportunities for development. IACTA is filling this gap to accelerate innovation, address unmet need, and advance the eye care industry.
IACTA’s leadership brings extensive experience with a history of success in ophthalmology, R&D execution, and pharmaceutical startups. Our team is dedicated to bringing the best ophthalmic innovations to market.
Ophthalmology is a niche therapeutic area that requires specific expertise
IACTA is led by former top executives from the leading eye care companies in the world. With their collective knowledge of global R&D operations, formulation development, and regulatory, they are driving IACTA to success.
CO-FOUNDER & CHIEF EXECUTIVE OFFICER
CO-FOUNDER & CHIEF ADMINISTRATIVE OFFICER
CO-FOUNDER & CHIEF BUSINESS OFFICER
CHIEF SCIENTIFIC OFFICER
CHIEF OPERATING OFFICER
CHIEF FINANCIAL OFFICER
CHIEF MEDICAL OFFICER
Learn more about our executive team
Our business partnerships
We’re partnering with the best in the pharmaceutical industry to bring patients effective and innovative eye care products
IACTA Pharmaceuticals and Pharmaleads to Develop the World’s First Epithelial Protective Drug Harnessing Endogenous Analgesia for the Topical Treatment of Acute and Chronic Ocular Pain
Ocular pain is a $10+ billion global market with significant unmet medical need. IACTA and Pharmaleads are teaming up to accelerate global development of DENKIs, leveraging expertise and resources of both companies.